Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03951766 · ClinicalTrials.gov registry record · NA
Version 2 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03951766: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03951766 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03951766, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The overall goal of this pilot study is to solicit feedback from nondaily smokers looking for smoking cessation support online (n=90) about Version 2 of a smartphone app investigators designed to support smoking cessation, and to test if within-person theorized mechanisms of change are occurring as participants undergo the app-assisted quit attempt. Data sources will be passively collected smartphone app usage data, surveys and, in a sub-sample (n=20), online video-conference user feedback sessions. Results will be used to guide the design of Version 3.0 of the "Smiling Instead of Smoking" (SiS) smartphone app. Specifically, the aims of this study are to: 1. Assess ease-of-use and helpfulness of the app, as rated by app users 6 weeks after their chosen smoking cessation date 2. Test if within-person changes occur in theorized mechanisms of behavior change as nondaily smokers undergo a SiS app assisted quit attempt 3. Identify app features in need of improvement, as identified by passively recorded app usage patterns, REDCap open-ended survey items, and, in a sub-sample, user feedback sessions (n=20)
Interventions
- BEHAVIORAL Smiling Instead of Smoking (SiS) App Version 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2020-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03951766
The ClinicalTrials.gov registry entry for NCT03951766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smiling Instead of Smoking (SiS) App Version 2 is the first listed.
NCT03951766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03951766 about?
NCT03951766 is a clinical study titled "Version 2 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)". The overall goal of this pilot study is to solicit feedback from nondaily smokers looking for smoking cessation support online (n=90) about Version 2 of a smartphone app investigators designed to support smoking cessation, and to test if within-person theorized mechanisms of change are occurring as ...
What is the current status of trial NCT03951766?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-06-24. Estimated completion is 2020-06-08.
What interventions are being tested in trial NCT03951766?
The interventions under investigation include: Smiling Instead of Smoking (SiS) App Version 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03951766?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.